Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Details)

v3.24.3
Stockholders’ Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Jul. 24, 2024
Oct. 07, 2020
Jan. 31, 2018
Nov. 30, 2021
Jul. 31, 2024
Jul. 31, 2023
May 31, 2023
Jan. 31, 2011
Stockholders’ Equity [Line Items]                
Common stock, par value per share (in Dollars per share)         $ 0.01 $ 0.01 $ 0.01  
Offering price             $ 30,000  
Percentage of aggregate gross proceeds             3.00%  
Sales agreement           $ 150,000    
Common stock, shares issued (in Shares)           276,479    
Net proceeds           $ 386    
Value of issuance of common stock         $ 615 1,079    
Total of agreement bonus         $ 1,404      
Shares of common stock (in Shares)   4,000,000            
Common stock granted (in Shares)         4,701,000      
Total intrinsic value of outstanding options, exercisable         $ 0 0    
Intrinsic value of options outstanding         0 0    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value         $ 3 $ 3    
Vesting period         3 years 3 years    
RSU vested shares (in Shares)         173,333      
RSU cancelled shares (in Shares)           100,000    
Vested shares (in Shares)           144,530    
Total unrecognized compensation cost related to non-vested         $ 256      
PSUs shares issued (in Shares)           25,200    
Restricted Stock Units (RSUs) [Member]                
Stockholders’ Equity [Line Items]                
Common stock granted (in Shares)   9,000,000            
Shares awarded (in Shares) 260,000     260,000 255,825 225,564    
Vesting period       3 years 1 year 1 year    
Fair market value at grant date       $ 881 $ 325 $ 300    
Forfeited shares (in Shares)         79,365      
Share based compensation expense         $ 318 150    
RSU vested shares (in Shares)         475,222      
RSU cancelled shares (in Shares)         179,363      
Phantom Share Units (PSUs) [Member]                
Stockholders’ Equity [Line Items]                
Share based compensation expense           $ 2    
Vested shares (in Shares)         4,817      
CEO [Member] | Restricted Stock Units (RSUs) [Member]                
Stockholders’ Equity [Line Items]                
Shares awarded (in Shares)         150,000 100,000    
Vesting period         3 years      
Fair market value at grant date         $ 207 $ 197    
Director [Member] | Restricted Stock Units (RSUs) [Member]                
Stockholders’ Equity [Line Items]                
Share based compensation expense         176      
Three Independent Directors [Member] | Restricted Stock Units (RSUs) [Member]                
Stockholders’ Equity [Line Items]                
Share based compensation expense         $ 150      
2011 Plan [Member]                
Stockholders’ Equity [Line Items]                
Stock units (in Shares)               3,000,000
Shares of common stock (in Shares)     2,000,000          
Common stock granted (in Shares)     5,000,000          
Common Stock [Member]                
Stockholders’ Equity [Line Items]                
Common stock, par value per share (in Dollars per share)         $ 0.01      
Issuance of common stock (in Shares)         487,852 843,100    
Value of issuance of common stock         $ 5 $ 8    
Common stock issued for asset purchase agreement (in Shares)         1,134,024 1,134,024    
Total of agreement bonus         $ 11 $ 1,404    
Shares awarded (in Shares)         624,567 125,731